IL4 and COVID-19: GSVA revealed MC IL‐4 + IL‐13 signatures enriched in atopic dermatitis and psoriasis, IFNγ in COVID‐19 infection and cystic fibrosis, IL‐33 in COVID‐19 and chronic obstructive pulmonary disease (COPD) and TGFβ in pulmonary fibrosis (PF) and chronic rhinosinusitis.